Novel Therapies in Acute Myeloid Leukemia.

Author: MukherjeeSudipto, SekeresMikkael A

Paper Details 
Original Abstract of the Article :
OBJECTIVE: To provide a comprehensive review of evidence-based data on the newly approved therapeutic agents in acute myeloid leukemia (AML) with regards to appropriate indications for use, efficacy, and safety. DATA SOURCES: Published clinical trials and observational studies. CONCLUSION: Optimal...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.soncn.2019.150955

データ提供:米国国立医学図書館(NLM)

Novel Therapies in Acute Myeloid Leukemia: Expanding Treatment Options

Acute myeloid leukemia (AML), a type of blood cancer, is a formidable foe in the vast desert of hematological malignancies. This research provides a comprehensive review of newly approved therapeutic agents for AML. The study highlights the expanding treatment landscape for AML, with a range of new agents targeting specific molecular pathways and mutations. However, the researchers emphasize the importance of personalized treatment decisions based on individual patient characteristics, such as performance status, mutational profile, and prior therapies.

Personalized Treatment: A Key to Success in AML

The study underscores the importance of tailoring treatment decisions for AML to the individual patient. The increasing availability of new therapies offers hope for patients with AML, but it also highlights the need for careful patient selection and monitoring to optimize treatment outcomes.

AML: A Challenging Landscape of Treatment

AML is a challenging disease with a complex and evolving treatment landscape. This research provides a valuable overview of new therapies and their potential benefits and risks, highlighting the importance of personalized treatment approaches to optimize patient outcomes.

Dr.Camel's Conclusion

The desert of AML research continues to be a dynamic and challenging landscape. This review provides a comprehensive overview of novel therapies and their potential benefits and risks, underscoring the importance of personalized treatment approaches to optimize patient outcomes.

Date :
  1. Date Completed 2020-07-20
  2. Date Revised 2020-07-20
Further Info :

Pubmed ID

31759818

DOI: Digital Object Identifier

10.1016/j.soncn.2019.150955

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.